Your T Cell Company

Experts for immune diagnostic systems


T-Track® CMV

T-Track® CMV is a CE-marked in vitro diagnostic (IVD) test for highly sensitive detection of CMV-specific effector cells. Possible immune monitoring applications of the T-Track® CMV ELISpot assay are:

  • Assistance in antiviral therapy decision-making
  • Assessment of CMV-specific cell-mediated immunity
  • Monitoring of immune reconstitution

Go to product

Product overview

ELISpot-based solutions for diagnostic and research applications. Benefit from highest specificity combined with a standardized and fast read-out for improved results with our:

  • T-Track® CMV (IVD)
  • IFN-γ ELISpot kits and plates (RUO)
  • T-activated® proteins

Go to products

Technology platforms

Efficient stimulation of a broad spectrum of clinically-relevant effector cells or discrimination between active and memory T cells for innovative immune diagnostic solutions. Learn more about possible applications, read-outs and advantages of the:

  • T-activation® Technology
  • Reverse T Cell Technology (RTT)

Learn more


Newsroom


February 08, 2018 – T-Track® CMV is a Highly Sensitive Immune-Monitoring Tool for Risk Stratification of Renal Transplant Recipients

A new peer-reviewed scientific publication covers T-Track® CMV in a clinical study with kidney transplant patients.

Read more

September 27, 2017 - Lophius and Mediphos sign exclusive distribution partnership for T-Track® CMV in the Benelux countries

Lophius Biosciences GmbH and Mediphos Medical Supplies B.V. today announced their distribution partnership for the in vitro diagnostic test T-Track® CMV.

Read more

September 1, 2017 - Launch of the Next Generation T-Track® CMV Immune Monitoring Tool

Today Lophius Biosciences launched the next generation of its in vitro diagnostic test T-Track® CMV for the risk stratification of human cytomegalovirus (CMV)-related clinical complications in...

Read more

May 31, 2017 – Lophius Biosciences Receives Public Grant for the Development of an Advanced Diagnostic Tuberculosis Test

Lophius Biosciences GmbH today announced that it has been awarded a public grant funding of 0.65 MEUR from the German Federal Ministry of Education and Research to develop a blood based diagnostic...

Read more
This function requires IE9 or higher.
You can update your browser under:
http://windows.microsoft.com/de-DE/internet-explorer/download-ie